Skip to main content

Table 1 General characteristics of the study population

From: Effects of recombinant LH supplementation to recombinant FSH during induced ovarian stimulation in the GnRH-agonist protocol: a matched case-control study

 

Total

Group I

(no r-LH)

Group II

(r-LH)

P

Female age

32.7 ± 3.7

32.7 ± 3.7

32.7 ± 3.7

ns

Distribution of females

    

<30 y

19.7 (48)

19.7 (24)

19.7 (24)

ns

30–35 y

54.1(132)

54.1 (66)

54.1 (66)

 

36–39 y

26.2 (61)

26.2 (32)

26.2 (32)

 

Male age

37.2 ± 6.8

37.2 ± 6.3

37.1 ± 7.2

ns

Infertility Factor

    

-Male factor

45.5(111)

48.4 (59)

42.6 (52)

ns

-Idiopathic

16.8 (41)

14.0 (17)

19.7 (24)

 

-Endometriosis

13.5 (33)

9.8 (12)

17.2 (21)

 

-Tubal–peritoneal

13.5 (33)

17.2 (21)

9.8 (12)

 

-Tubal–peritoneal+endometriosis

4.9 (12)

5.7 (7)

4.1 (5)

 

-Tubal–peritoneal + male

2.9 (7)

3.3 (4)

2.5 (3)

 

-Endometriosis + male

2.9 (7)

1.6 (2)

4.1 (5)

 

BMI (kg/m2)

23.2 ± 2.9

23.1 ± 3.0

23.4 ± 2.9

ns

Infertility

    

-Primary

77 (188)

77.9 (95)

76.2 (93)

ns

-Secondary

23 (56)

22.1 (27)

23.8 (29)

 

Duration of infertility (y)

4.6 ± 3.5

5.2 ± 4.1

4.0 ± 3.0

ns

basal FSH (mUI/ml)

5.9 ± 2.6

5.2 ± 1.9

6.4 ± 3.1

ns

basal LH (mUI/ml)

5.4 ± 3.4

4.8 ± 2.6

6.1 ± 4.1

ns

basal Estradiol (pg/ml)

47.7 ± 23.5

48.3 ± 28.8

47.1 ± 23.6

ns

  1. ns: not significant
  2. Values are mean ± SD or %(n)